KIC
ABBV icon

Keating Investment Counselors’s AbbVie ABBV Stock Holding History

Keating Investment Counselors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Sell
935
-300
-24% -$64.5K 0.06% 54
2026
Q1 		$269K Sell
1,235
-535
-30% -$119K 0.07% 52
2025
Q4 		$404K Sell
1,770
-140
-7% -$31.9K 0.11% 48
2025
Q3 		$442K Sell
1,910
-36
-2% -$7.33K 0.13% 50
2025
Q2 		$361K Buy
1,946
+136
+8% +$25.3K 0.11% 53
2025
Q1 		$379K Sell
1,810
-200
-10% -$38.9K 0.11% 53
2024
Q4 		$357K Hold
2,010
– – 0.11% 54
2024
Q3 		$397K Sell
2,010
-100
-5% -$18.7K 0.12% 52
2024
Q2 		$362K Sell
2,110
-3,180
-60% -$527K 0.12% 55
2024
Q1 		$963K Sell
5,290
-3,888
-42% -$670K 0.31% 43
2023
Q4 		$1.42M Hold
9,178
– – 0.51% 38
2023
Q3 		$1.37M Buy
9,178
+3,070
+50% +$451K 0.46% 38
2023
Q2 		$823K Hold
6,108
– – 0.3% 46
2023
Q1 		$973K Sell
6,108
-2,550
-29% -$390K 0.37% 42
2022
Q4 		$1.4M Buy
+8,658
New +$1.33M 0.55% 38
2022
Q2 		– Sell
-2,220
Closed -$360K – 59
2022
Q1 		$360K Hold
2,220
– – 0.15% 55
2021
Q4 		$301K Hold
2,220
– – 0.13% 56
2021
Q3 		$239K Hold
2,220
– – 0.11% 59
2021
Q2 		$250K Hold
2,220
– – 0.11% 58
2021
Q1 		$240K Hold
2,220
– – 0.12% 56
2020
Q4 		$238K Buy
+2,220
New +$213K 0.12% 56
2020
Q3 		– Sell
-2,220
Closed -$218K – 59
2020
Q2 		$218K Buy
+2,220
New +$195K 0.12% 57
2019
Q1 		– Sell
-2,240
Closed -$207K – 65
2018
Q4 		$207K Hold
2,240
– – 0.1% 65
2018
Q3 		$212K Sell
2,240
-1,150
-34% -$109K 0.09% 64
2018
Q2 		$314K Sell
3,390
-1,785
-34% -$174K 0.15% 58
2018
Q1 		$490K Sell
5,175
-1,400
-21% -$154K 0.23% 49
2017
Q4 		$636K Hold
6,575
– – 0.27% 44
2017
Q3 		$584K Hold
6,575
– – 0.25% 49
2017
Q2 		$477K Hold
6,575
– – 0.21% 54
2017
Q1 		$428K Hold
6,575
– – 0.19% 54
2016
Q4 		$412K Buy
6,575
+100
+2% +$6.1K 0.19% 52
2016
Q3 		$408K Sell
6,475
-368
-5% -$23.8K 0.2% 53
2016
Q2 		$424K Buy
6,843
+3,000
+78% +$183K 0.21% 51
2016
Q1 		$220K Sell
3,843
-35,240
-90% -$1.96M 0.11% 57
2015
Q4 		$2.31M Sell
39,083
-160
-0.4% -$9.22K 1.16% 34
2015
Q3 		$2.13M Hold
39,243
– – 1.15% 35
2015
Q2 		$2.64M Sell
39,243
-1,300
-3% -$84.9K 1.34% 33
2015
Q1 		$2.37M Sell
40,543
-100
-0.2% -$6.04K 1.19% 33
2014
Q4 		$2.66M Sell
40,643
-1,885
-4% -$119K 1.33% 32
2014
Q3 		$2.46M Sell
42,528
-4,200
-9% -$233K 1.27% 34
2014
Q2 		$2.64M Sell
46,728
-250
-0.5% -$13.1K 1.27% 33
2014
Q1 		$2.42M Buy
46,978
+400
+0.9% +$20.2K 1.2% 35
2013
Q4 		$2.46M Buy
46,578
+8,850
+23% +$435K 1.25% 33
2013
Q3 		$1.69M Buy
37,728
+18,815
+99% +$834K 0.94% 35
2013
Q2 		$782K Buy
+18,913
New +$827K 0.44% 43

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Keating Investment Counselors's ABBV Position: Q2 2026 in Review

Keating Investment Counselors reduced its AbbVie (ABBV) stake by 24% in Q2 2026, selling an estimated $64.5K and leaving 935 shares worth $235K. The position accounts for 0.06% of the portfolio, ranked #54.

Keating Investment Counselors first reported a position in ABBV in Q2 2013 and has held it in 45 quarters since. The position peaked at $2.66M in Q4 2014. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Keating Investment Counselors held 935 shares of AbbVie worth $235K as of Q2 2026.
  • Keating Investment Counselors sold 300 AbbVie shares in Q2 2026, an estimated $64.5K.
  • AbbVie made up 0.06% of Keating Investment Counselors's portfolio in Q2 2026, its #54 holding.
  • Keating Investment Counselors first reported a position in AbbVie in Q2 2013 and has held it in 45 quarters since.
  • Keating Investment Counselors's AbbVie position peaked at $2.66M in Q4 2014.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Keating Investment Counselors's 13F filing for Q2 2026, filed 16 Jul 2026.